https://pharmadog.xyz/news/671635 pharmadog en 2026-11-12T11:17:18.000Z Blackstone pledges up to $1.5 billion to fund Pfizer's obesity drug berobenatide development https://pharmadog.xyz/news/671345 pharmadog en 2026-11-12T09:30:00.000Z Newly elected doctors and scientists aim to rebuild public trust in science after midterm wins https://pharmadog.xyz/news/671343 pharmadog en 2026-11-12T09:30:00.000Z New governors should prioritize health hires, vaccination data, and a focused agenda https://pharmadog.xyz/news/671344 pharmadog en 2026-11-12T09:30:00.000Z Study finds Black Americans share many concerns with MAHA despite low overall support https://pharmadog.xyz/news/670819 pharmadog en 2026-11-12T06:01:00.000Z Biopharma layoffs rise YoY in October but overall trend points down for 2026 https://pharmadog.xyz/news/670820 pharmadog en 2026-11-12T06:01:00.000Z Biopharma job postings rise 31% YoY in Q3 while layoffs plunge 90% https://pharmadog.xyz/news/670651 pharmadog en 2026-11-12T05:00:00.000Z Biopharma hiring surge in New Jersey as BioSpace lists ~300 open positions across 10 companies https://pharmadog.xyz/news/671275 pharmadog en 2026-11-12T03:57:00.000Z Neurosterix secures $105M Series B to launch phase 2 schizophrenia trial https://pharmadog.xyz/news/671274 pharmadog en 2026-11-12T03:35:00.000Z Pfizer taps Blackstone for up to $1.5B to pave path to GLP-1's obesity launch https://pharmadog.xyz/news/669111 pharmadog en 2026-11-11T21:37:27.000Z Study of 100,000 diverse Americans uncovers thousands of new drug-response genetic variants https://pharmadog.xyz/news/669067 pharmadog en 2026-11-11T21:00:55.000Z Neurosterix raises $105 million Series B to advance schizophrenia candidate https://pharmadog.xyz/news/668899 pharmadog en 2026-11-11T20:20:26.000Z Hims & Hers pivots to branded GLP-1 drugs after striking deal with Eli Lilly https://pharmadog.xyz/news/668775 pharmadog en 2026-11-11T19:44:07.000Z U.S. 'most-favored nations' policy prompts drugmakers to reconsider overseas launches https://pharmadog.xyz/news/668439 pharmadog en 2026-11-11T17:47:53.000Z MAHA backs convicted rapist Russell Brand, highlighting toxic culture within movement https://pharmadog.xyz/news/668251 pharmadog en 2026-11-11T16:20:46.000Z FDA issues warning letters to two Chinese API makers for refusing record requests https://pharmadog.xyz/news/668291 pharmadog en 2026-11-11T16:11:00.000Z Study warns German drug price hikes could raise US Medicaid spending by $300 million https://pharmadog.xyz/news/668103 pharmadog en 2026-11-11T16:00:00.000Z Study proposes new obesity metric that could reverse diagnoses for millions, aiming for more precise care https://pharmadog.xyz/news/668059 pharmadog en 2026-11-11T15:44:23.000Z Flagship Pioneering combines Valo Health and Montai Therapeutics into a single company https://pharmadog.xyz/news/668083 pharmadog en 2026-11-11T15:23:20.000Z PepGen stock surges as DM1 oligonucleotide PGN-EDODM1 shows record splicing correction in Phase 2 https://pharmadog.xyz/news/668104 pharmadog en 2026-11-11T15:20:23.000Z Former ER doctor argues that limiting data input can improve clinical AI tools https://pharmadog.xyz/news/667975 pharmadog en 2026-11-11T15:15:08.000Z Capricor trims 10% of workforce as FDA decision on Duchenne cell therapy approaches https://pharmadog.xyz/news/667995 pharmadog en 2026-11-11T15:07:28.000Z Senate Health Committee Schedules Vote on FDA Commissioner Nominee Heidi Overton https://pharmadog.xyz/news/667976 pharmadog en 2026-11-11T15:00:29.000Z Capricor boosts manufacturing capacity as FDA decision on DMD cell therapy looms https://pharmadog.xyz/news/667827 pharmadog en 2026-11-11T14:34:28.000Z Incoming Democratic committee chairs move to probe Trump-era most-favored-nation drug pricing deals https://pharmadog.xyz/news/667783 pharmadog en 2026-11-11T14:00:48.000Z Beeline Medicines reports promising Phase 2 results for lupus using repurposed Bristol Myers drug https://pharmadog.xyz/news/667615 pharmadog en 2026-11-11T13:52:49.000Z UK science minister urges life-science firms to boost domestic investment as government raises medicine spending https://pharmadog.xyz/news/667847 pharmadog en 2026-11-11T13:42:00.000Z AstraZeneca acquires Omniose to boost conjugate vaccine platform as FDA flags vision-loss risk for GLP-1 drugs https://pharmadog.xyz/news/134233 pharmadog en 2026-11-11T13:22:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/667447 pharmadog en 2026-11-11T13:00:05.000Z VectorY Therapeutics raises $83.5M Series A to develop brain-targeted antibody gene therapy https://pharmadog.xyz/news/667491 pharmadog en 2026-11-11T12:56:13.000Z U.S. faces possible loss of measles elimination status as WHO panel convenes https://pharmadog.xyz/news/123087 pharmadog en 2026-11-11T12:22:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/667279 pharmadog en 2026-11-11T11:57:06.000Z Merck KGaA receives FDA approval for Abbisko-licensed joint tumor therapy https://pharmadog.xyz/news/667136 pharmadog en 2026-11-11T10:44:50.000Z Novartis' Zolgensma linked to tumors as FDA probes gene therapy and orders GLP-1 eye risk warnings https://pharmadog.xyz/news/666988 pharmadog en 2026-11-11T09:30:00.000Z Federal panel overseeing preventive care receives blanket ethics waivers despite members' pharma and practice conflicts https://pharmadog.xyz/news/666987 pharmadog en 2026-11-11T09:30:00.000Z MDCalc unveils CrossCover to boost clinician confidence in AI chatbot answers while protecting privacy https://pharmadog.xyz/news/666989 pharmadog en 2026-11-11T09:30:00.000Z Health-care providers sue employers over out-of-network medical bills https://pharmadog.xyz/news/666990 pharmadog en 2026-11-11T09:30:00.000Z Rising food costs and aid cuts leave low-income parents unable to risk nutritious meals for picky eaters https://pharmadog.xyz/news/667758 pharmadog en 2026-11-11T09:18:00.000Z Flagship-backed Valo Health merges with Montai Therapeutics to boost AI-driven drug pipeline https://pharmadog.xyz/news/667590 pharmadog en 2026-11-11T07:49:00.000Z BioNTech spends $205 million on FDA priority review voucher to accelerate oncology pipeline https://pharmadog.xyz/news/666188 pharmadog en 2026-11-11T05:37:00.000Z China’s five-year plan positions it to become a global leader in innovative biopharma by 2030 https://pharmadog.xyz/news/666189 pharmadog en 2026-11-11T05:27:00.000Z US biotech faces growth slowdown as China’s coordinated investment threatens industry https://pharmadog.xyz/news/667086 pharmadog en 2026-11-11T04:49:00.000Z Capricor cuts 10% of staff as it readies FDA decision on DMD cell therapy, NextCure trims workforce ahead of merger https://pharmadog.xyz/news/667591 pharmadog en 2026-11-11T04:47:00.000Z Amgen builds Sjögren’s case with detailed phase 3 data ahead of Novartis showdown https://pharmadog.xyz/news/666306 pharmadog en 2026-11-11T01:25:00.000Z Abbott nabs FDA approval, CE Mark for implantable cardioverter-defibrillator lead https://pharmadog.xyz/news/669585 pharmadog en 2026-11-11T00:00:00.000Z FDA releases draft guidance for early-phase first-in-human studies of solid-tumor therapies https://pharmadog.xyz/news/665111 pharmadog en 2026-11-10T23:55:00.000Z Democratic committee chairs send letters to 27 drugmakers demanding details on Trump-era MFN pricing agreements https://pharmadog.xyz/news/664899 pharmadog en 2026-11-10T22:06:43.000Z HHS Secretary RFK Jr. stays optimistic about Make America Healthy Again initiative despite midterm setbacks https://pharmadog.xyz/news/664607 pharmadog en 2026-11-10T20:05:20.000Z Senators Wyden and Sanders unite on push to lower Medicare eligibility age by a decade https://pharmadog.xyz/news/664307 pharmadog en 2026-11-10T19:31:21.000Z Mirum readies FDA filing after positive Phase 3 results for hepatitis D therapy https://pharmadog.xyz/news/664331 pharmadog en 2026-11-10T19:06:56.000Z FDA's new rare-disease framework faces first test with Capricor's Duchenne therapy decision https://pharmadog.xyz/news/664183 pharmadog en 2026-11-10T18:04:30.000Z Former Eli Lilly sales rep sues, alleging termination after raising concerns over off-label promotion of Mounjaro for weight loss https://pharmadog.xyz/news/664015 pharmadog en 2026-11-10T17:18:42.000Z Men turn to chatbots for therapy as earnings season unfolds https://pharmadog.xyz/news/663971 pharmadog en 2026-11-10T17:17:29.000Z Democrats demand unredacted drug pricing agreements from pharma firms after midterm victories https://pharmadog.xyz/news/664035 pharmadog en 2026-11-10T17:06:00.000Z Beam Therapeutics reports successful pivotal trial of base editing sickle cell therapy https://pharmadog.xyz/news/663803 pharmadog en 2026-11-10T16:23:21.000Z Beam Therapeutics' base-edited sickle cell therapy shows success in Phase 1/2 trial https://pharmadog.xyz/news/663827 pharmadog en 2026-11-10T16:10:45.000Z Coherus trims workforce by 30% as Gyre Therapeutics also cuts staff after acquisition https://pharmadog.xyz/news/663804 pharmadog en 2026-11-10T16:09:58.000Z PepGen reports positive Phase 2 data for PGN-EDODM1 in myotonic dystrophy https://pharmadog.xyz/news/663659 pharmadog en 2026-11-10T15:52:33.000Z BIO urges US to create White House biotech office and streamline trials to stay ahead of China https://pharmadog.xyz/news/663635 pharmadog en 2026-11-10T15:46:44.000Z Employers and consumers poised to reshape healthcare, says Health Tech Day discussion https://pharmadog.xyz/news/663636 pharmadog en 2026-11-10T15:34:19.000Z White House pushes Heidi Overton nomination for FDA commissioner as confirmation window narrows https://pharmadog.xyz/news/663660 pharmadog en 2026-11-10T15:23:08.000Z Beam Therapeutics' base-edited risto-cel shows 12-month pain-crisis freedom in sickle cell trial, paving way for FDA filing https://pharmadog.xyz/news/664875 pharmadog en 2026-11-10T15:11:00.000Z Oura to buy AI virtual care firm Counsel Health for $625 million, expanding in-app health services https://pharmadog.xyz/news/663661 pharmadog en 2026-11-10T15:04:56.000Z Bayer's Sunharbo becomes first FDA-approved factor XIa inhibitor blood thinner https://pharmadog.xyz/news/663491 pharmadog en 2026-11-10T14:26:23.000Z Delix raises $100M to advance at-home psychedelic without hallucinatory effects https://pharmadog.xyz/news/663512 pharmadog en 2026-11-10T14:25:24.000Z FDA approves Bayer's Sunharbo, a new class drug to lower stroke recurrence https://pharmadog.xyz/news/663467 pharmadog en 2026-11-10T14:08:44.000Z OpenAI’s health chief envisions ChatGPT Health moving patients from answers to actionable steps https://pharmadog.xyz/news/663343 pharmadog en 2026-11-10T13:38:35.000Z Dutch regulators probe Biogen over exclusive MS test for Tysabri patients https://pharmadog.xyz/news/664538 pharmadog en 2026-11-10T13:34:00.000Z Beam Therapeutics reports year-long reduction in sickle cell crises in phase 1/2 risto-cel study https://pharmadog.xyz/news/663323 pharmadog en 2026-11-10T13:23:18.000Z Altimmune to discuss Phase 3 design for alcohol use disorder drug with FDA https://pharmadog.xyz/news/663344 pharmadog en 2026-11-10T13:00:00.000Z Pharma access plans rise to 69% of late-stage drugs but gaps remain for non-communicable diseases https://pharmadog.xyz/news/663175 pharmadog en 2026-11-10T12:49:35.000Z Flu season this year appears to be affecting teens and young adults more severely, experts say https://pharmadog.xyz/news/668379 pharmadog en 2026-11-10T12:44:00.000Z Start Center for Cancer Research launches Italy’s first early-phase oncology trial site with IFO https://pharmadog.xyz/news/663067 pharmadog en 2026-11-10T12:05:00.000Z PepGen reports promising early results for myotonic dystrophy type 1 drug in six-patient trial